CYTK

Cytokinetics, Incorporated News Headlines

$4.16
*  
0.0699
1.71%
Get CYTK Alerts
*Delayed - data as of Jul. 30, 2014  -  Find a broker to begin trading CYTK now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Market Wrap for Tuesday, June 18: Stocks Rally Ahead of Fed Statement
6/18/2013 4:22:20 PM - Benzinga

Why The Amgen And Cytokinetics Agreement Is Good News
6/13/2013 5:35:00 AM - Seeking Alpha

Cytokinetics Receives A Vote Of Confidence From Amgen
6/13/2013 4:43:00 AM - Seeking Alpha

4 Biotech Stocks Offering Potential, Pipeline And Price
5/29/2013 3:07:00 PM - Seeking Alpha

SmithOnStocks Opines On Recent Biotech News
5/13/2013 5:38:00 AM - Seeking Alpha

2 High Risk Biotech Stocks Under $2 That Could Yield A High Reward
4/17/2013 10:48:00 AM - Seeking Alpha

Cytokinetics: Key Issues For Beginning Phase III For Omecamtiv Mecarbil In Congestive Heart Failure
4/11/2013 1:14:00 PM - Seeking Alpha

Patients Dosed in Arena Study - Analyst Blog
4/9/2013 6:09:14 PM - Zacks.com

AZN Reports Data on Fostamatinib - Analyst Blog
4/8/2013 7:08:59 PM - Zacks.com

Data Presented on Bayer's ATX-101 - Analyst Blog
4/8/2013 6:10:38 PM - Zacks.com

Cytokinetics Begins CK-2127107 Study - Analyst Blog
4/5/2013 5:08:28 PM - Zacks.com

GHDX to Show Prostate Test Result - Analyst Blog
4/5/2013 4:06:16 PM - Zacks.com

Glaxo Eyes Benlysta Label Expansion - Analyst Blog
4/5/2013 3:09:05 PM - Zacks.com

QLT Sells PPDS Technology - Analyst Blog
4/5/2013 3:08:41 PM - Zacks.com

Elan Gets Takeover Clarity - Analyst Blog
4/4/2013 7:08:43 PM - Zacks.com

Update on Protalix Gaucher Study - Analyst Blog
4/4/2013 5:10:32 PM - Zacks.com

AstraZeneca Takes Over AlphaCore - Analyst Blog
4/4/2013 5:09:40 PM - Zacks.com

Orphan Status for Insmed's Arikace - Analyst Blog
4/4/2013 4:07:41 PM - Zacks.com

ARNA/Eisai's Belviq Filed in Mexico - Analyst Blog
4/3/2013 4:19:58 PM - Zacks.com

Elan Sells Off Tysabri Stake - Analyst Blog
4/3/2013 2:21:56 PM - Zacks.com

BioMarin Files CTA for BMN-190 - Analyst Blog
4/3/2013 10:22:52 AM - Zacks.com

Vivus Opts for Royalty Financing - Analyst Blog
4/2/2013 7:21:59 PM - Zacks.com

Isis Publishes Encouraging Data - Analyst Blog
4/2/2013 5:25:30 PM - Zacks.com

Celgene Reaches 52-Week High - Analyst Blog
4/2/2013 10:08:11 AM - Zacks.com

Cytokinetics Growth-By-Partnership Strategy Looks Viable When It Comes To CK-2127107
4/2/2013 3:27:00 AM - Seeking Alpha